Baldus, Claudia D <br/><br/>
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.  [electronic resource] 

 -  Blood  Sep 2003 
 - 1613-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2003-02-0359  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Genetic Markers<br/>Genetic Predisposition to Disease--epidemiology<br/>Humans<br/>Karyotyping<br/>Leukemia, Myeloid--epidemiology<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Proteins--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Risk Factors<br/>Treatment Outcome